It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
Surgical site infections and antimicrobial resistance remain major challenges globally
The trial tested six injectable doses and three oral doses over as long as 36 weeks
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
The trials, designed to assess whether semaglutide could slow cognitive decline, showed no significant difference compared to placebo in the progression of Alzheimer’s disease over two years
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
Subscribe To Our Newsletter & Stay Updated
